Navigation Links
New Polio Vaccine Shows Major Advantages: Study

TUESDAY, Oct. 26 (HealthDay News) -- A new bivalent oral vaccine that targets two deadly strains of polio -- types 1 and 3 -- triggers a stronger immune response than the existing trivalent vaccine and an immune response that's similar to monovalent vaccines, a new study shows.

Use of trivalent and monovalent vaccines has reduced the number of countries where polio is endemic from more than 125 in 1988 to just four today. Transmission of polio virus types 1 and 3 persists in parts of Afghanistan, Pakistan, India and Nigeria.

The bivalent oral vaccine is already widely used in efforts to halt transmission of polio virus types 1 and 3, but this study set out to examine whether it triggers as much immunity as the other vaccines.

Between August and December 2008, researchers gave 830 newborns in India either the monovalent, bivalent or trivalent vaccines in two doses, including one at birth and one 30 days later. Antibody levels were measured in blood samples before vaccination and after the first and second doses of the vaccines.

Overall, the immune response induced by the bivalent vaccine was significantly higher than the trivalent vaccine and similar to the monovalent vaccine, the investigators found.

The study was released online Oct. 25 in advance of publication in an upcoming print issue of The Lancet.

"The major advantages of the bivalent vaccine ... is that it will enhance individual and population immunity simultaneously for both poliovirus types 1 and 3, without any serious loss in immunogenicity compared with the [monovalent vaccines]," the researchers said in a news release from the publisher.

More information

The American Academy of Family Physicians has more about polio vaccine.

-- Robert Preidt

SOURCE: The Lancet, news release, Oct. 25, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Rotary International and I Imagine Studio Have Teamed up to Helps Kick Polio out of Africa
2. Polio outbreak in Tajikistan is cause for alarm
3. Vaccine May Prevent TB in People With HIV
4. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
5. New strategy produces promising advance in cancer vaccines
6. Screens, Vaccine for HPV Less Beneficial in Older Women
7. New Technology Could Widen Reach of Vaccines
8. Texas-based consortium announces groundbreaking vaccine research program
9. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
10. Possible vaccine for mesothelioma proven safe
11. Groundbreaking research to find vaccine for hepatitis C
Post Your Comments:
Related Image:
New Polio Vaccine Shows Major Advantages: Study
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: